Want to see JP:7679 full AI Analyst Report?
7679 Stock Chart & Stats
¥2167.00
-¥102.00(-4.91%)
At close: 4:00 PM EST
¥2167.00
-¥102.00(-4.91%)
Day’s Range― - ―
52-Week Range¥1,609.00 - ¥2,340.00
Previous CloseN/A
Volume101.50K
Average Volume (3M)32.44K
Market Cap
¥35.67B
Enterprise Value¥53.22K
Total Cash (Recent Filing)¥10.01B
Total Debt (Recent Filing)¥34.60B
Price to Earnings (P/E)8.9
Beta0.50
Next Earnings
Oct 01, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield1.63%
Share Statistics
EPS (TTM)206.40
Shares Outstanding19,740,220
10 Day Avg. Volume22,110
30 Day Avg. Volume32,443
Financial Highlights & Ratios
PEG Ratio-1.88
Price to Book (P/B)1.01
Price to Sales (P/S)0.25
P/FCF Ratio-4.91
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Consistent Revenue GrowthSustained mid-to-high single-digit revenue growth over multiple years indicates durable demand for the company’s drugstore offerings and expanding footprint or same-store sales. That steady top-line trend supports capacity to reinvest in stores, merchandising, and supply chain over the medium term.
Stable Operating ProfitabilityConsistent, if thin, operating profitability provides predictable operating cash inflows and demonstrates repeatable retail economics in a competitive pharmacy market. Stable margins, even at modest levels, underpin the business’s ability to cover fixed costs and sustain operations across cycles.
Built Equity / Solid Capital BaseA steadily built equity base improves financial resilience and supports access to funding for store expansion or working capital. This capital foundation strengthens the firm’s ability to withstand temporary earnings shocks and pursue strategic investments without immediate reliance on short-term market funding.
Bears Say
Volatile And Weak Free Cash FlowMaterial swings into negative free cash flow reduce internal funding for capex, dividends, or debt repayment and force reliance on external financing. Persistently weak FCF impairs long-term financial flexibility and raises the risk that operations or growth initiatives cannot be self-funded.
Rising Leverage From 2026 Debt Step-upA meaningful jump in debt weakens solvency metrics and raises interest and refinancing risks, particularly if cash conversion is deteriorating. Higher leverage constrains strategic choices, increases fixed financial costs, and heightens vulnerability to any downturn in retail traffic or margin pressure.
Margin Compression TrendProgressive margin erosion suggests rising input costs or tougher pricing competition, which undermines the business’s ability to generate incremental profit from revenue growth. If unchecked, compression reduces returns on capital and limits the company’s capacity to invest while maintaining shareholder returns.
Yakuodo Holdings Co., Ltd. News
7679 FAQ
What was Yakuodo Holdings Co., Ltd.’s price range in the past 12 months?
Yakuodo Holdings Co., Ltd. lowest stock price was ¥1609.00 and its highest was ¥2340.00 in the past 12 months.
What is Yakuodo Holdings Co., Ltd.’s market cap?
Yakuodo Holdings Co., Ltd.’s market cap is ¥35.67B.
When is Yakuodo Holdings Co., Ltd.’s upcoming earnings report date?
Yakuodo Holdings Co., Ltd.’s upcoming earnings report date is Oct 01, 2026 which is in 62 days.
How were Yakuodo Holdings Co., Ltd.’s earnings last quarter?
Yakuodo Holdings Co., Ltd. released its earnings results on Jul 06, 2026. The company reported ¥51.33 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is Yakuodo Holdings Co., Ltd. overvalued?
According to Wall Street analysts Yakuodo Holdings Co., Ltd.’s price is currently Overvalued.
Does Yakuodo Holdings Co., Ltd. pay dividends?
Yakuodo Holdings Co., Ltd. pays a Annually dividend of ¥30 which represents an annual dividend yield of 1.63%. See more information on Yakuodo Holdings Co., Ltd. dividends here
What is Yakuodo Holdings Co., Ltd.’s EPS estimate?
Yakuodo Holdings Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Yakuodo Holdings Co., Ltd. have?
Yakuodo Holdings Co., Ltd. has 19,740,220 shares outstanding.
What happened to Yakuodo Holdings Co., Ltd.’s price movement after its last earnings report?
Yakuodo Holdings Co., Ltd. reported an EPS of ¥51.33 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 2.51%.
Which hedge fund is a major shareholder of Yakuodo Holdings Co., Ltd.?
Currently, no hedge funds are holding shares in JP:7679
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Yakuodo Holdings Co., Ltd.
YAKUODO HOLDINGS Co., Ltd. primarily oversees the operation of drugstores throughout Japan via its various subsidiary entities. This enterprise, established in 1978, manages a total of 358 retail locations and is officially headquartered in Morioka, Japan.
Technical Analysis
Sundrug Co
―
Sugi Holdings Co
―
TSURUHA Holdings
―
COSMOS Pharmaceutical Corporation
―
KUSURI NO AOKI HOLDINGS CO.,LTD.
―